N/A N=121 Personalized Feedback for Distress Intolerant Smokers
Anxiety Disorders · Depression · Psychological Distress
Primary: Rulers for Smoking Cessation — 7.37; 7.89; 8.58; 8.40 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=389 A Retrospective Review of Rib Fracture Pain Management at a London Major Trauma Centre
Rib Fractures · Pain, Acute
Primary: The Proportion of Patients With a Reduction in Pain — 101; 6; 15 Participants
Phase 3 N=391 Maternal Depression Treatment in HIV
Depression
Primary: Rate of Maternal HIV Viral Suppression — 128; 132 Participants
N/A N=75 Improving Aging in Place in Subsidized Housing
Physical Disability · Cognitive Impairment · Physical Activity
Primary: Change in Precipitating Events Project (PEP) Functional Status Scale From Baseline to 2 Months for Immediate Intervention Sites and Waitlist Control Sites — -1.3; 0.6…
N/A N=10 Literacy Promotion Using Automated Hovering
Parent-Child Relations · Parenting · Literacy
Primary: Acceptability Survey — 4; 3.3; 3.8 score on a scale
N/A N=459 Pediatric Adenotonsillectomy Trial for Snoring
Sleep-Disordered Breathing
Primary: Change From Baseline to 12 Months in Caregiver-reported Behavior Rating Inventory of Executive Function (BRIEF) Global Executive Composite (GEC) T Score — -1.90; -3.08…
N/A N=310 Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
Pseudophakia
Primary: Non-inferiority of Target-corrected Binocular Intermediate (66 cm) Visual Acuity With Offset — 0.20; 0.19 LogMAR — p=<0.05
N/A N=80 Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma
Hepatocellular Carcinoma
Primary: Number of Paticipants With Complete Tumor Response After the First 3 Treatments — 35; 18 Participants
N/A N=32 Registry Study of Revcovi Treatment in Patients With ADA-SCID
Adenosine Deaminase Severe Combined Immunodeficiency
Primary: Number of Subjects Meeting the Toxicity Threshold for Deoxyadenosine Nucleotide (dAXP) Concentration at the Last Measurement — 6; 17; 4 Participants
N/A N=16 A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.
Hemophilia A
Primary: Number of Participants With Adverse Events — 2 Participants
N/A N=114 Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle
Infertility Unexplained · Infertility, Male · DNA Damage
Primary: DNA Fragmentation as a Predictor of Live Birth Rate — 32 Participants — p=0.04
Phase 4 N=26 Effects of Genotype on Resting State Connectivity During Methamphetamine Administration
Methamphetamine-dependence
Primary: Functional Connectivity During Resting State Magnetic Resonance Imaging (MRI) — 0.91; 0.52; 0.54; 0.32 Fisher's Z-score
N/A N=220 Facilitating COVID-19 Test for Korean Americans Through Korean Schools in Northern California
Educational Activities
Primary: Proportion of Participants Who Has Been Tested for COVID-19 During the Study Period — 34; 51 Participants
Phase 1 N=41 COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults
Covid19
Primary: Number of Participants With Medically Attended Adverse Events (MAAE) — 0; 0; 0; 1 Participants
N/A N=47 Varian ProBeam Proton Therapy System China Clinical Trial (Hefei)
Tumor, Solid
Primary: Percentage of Participants With Disease Control — 100 percentage